{"name": "CNS Therapeutics",
 "permalink": "cns-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/cns-therapeutics",
 "homepage_url": "http://cnstherapeutics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@cnstherapeutics.com",
 "phone_number": "651-207-6959",
 "description": "",
 "created_at": "Tue Sep 25 09:39:37 UTC 2012",
 "updated_at": "Tue Sep 25 09:44:17 UTC 2012",
 "overview": "\u003Cp\u003ECNS Therapeutics is a private company based in St. Paul, Minn. CNS Therapeutics develops and markets safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system to treat neurological disorders and chronic pain. In addition to its first FDA-approved product, Gablofen, CNS Therapeutics is currently collaborating with U.S. and international scientific experts to develop and test new treatments for pain and Parkinson\u0026#8217;s disease. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       40],
      "assets/images/resized/0021/2926/212926v1-max-150x150.jpg"],
     [[215,
       58],
      "assets/images/resized/0021/2926/212926v1-max-250x250.jpg"],
     [[215,
       58],
      "assets/images/resized/0021/2926/212926v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": null,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://finance.yahoo.com/news/covidien-unit-acquire-cns-therapeutics-123228257.html",
   "source_description": "Covidien unit to acquire CNS Therapeutics for approximately $100M",
   "acquired_year": 2012,
   "acquired_month": 9,
   "acquired_day": 24,
   "acquiring_company":
    {"name": "Mallinckrodt",
     "permalink": "mallinckrodt",
     "image": null}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "332 Minnesota St.",
    "address2": "",
    "zip_code": "55101",
    "city": "St. Paul",
    "state_code": "MN",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        107],
       "assets/images/resized/0021/2927/212927v1-max-150x150.jpg"],
      [[250,
        178],
       "assets/images/resized/0021/2927/212927v1-max-250x250.jpg"],
      [[450,
        321],
       "assets/images/resized/0021/2927/212927v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}